Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Axsome Therapeutics Inc., 3 years.
Axsome Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Axsome Therapeutics Inc. June 5, 202673.6%
-
Axsome Therapeutics Inc. June 2, 202363.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 8, 2026 | Axsome Therapeutics Inc. | Option exercise | +1,429 | — | — |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Option exercise | +6,231 | $8.02 | $49,973 |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Open-market sale | −6,231 | $165.18 | $1,029,237 |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Option exercise | +31,346 | $4.95 | $155,163 |
| Dec 31, 2025 | Axsome Therapeutics Inc. | Open-market sale | −31,346 | $165.18 | $5,177,732 |
| Sep 5, 2025 | Axsome Therapeutics Inc. | Option exercise | +9,127 | $9.00 | $82,143 |
| Sep 5, 2025 | Axsome Therapeutics Inc. | Open-market sale | −9,127 | $125.07 | $1,141,514 |
| Sep 11, 2024 | Axsome Therapeutics Inc. | Option exercise | +11,016 | $3.67 | $40,429 |
| Sep 11, 2024 | Axsome Therapeutics Inc. | Open-market sale | −11,016 | $91.31 | $1,005,871 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.